Gizmodo

New research released on Wednesday suggests that Ozempic and similar medications may have unexpected side effects. Doctors in Massachusetts have found a link between the drug’s active ingredient semaglutide and a higher risk of a rare condition that can cause blindness called nonarteritic anterior ischemic optic…

Read more...

Gizmodo

Children and teens with high body mass index should be guided toward intensive lifestyle interventions to manage their weight, an influential panel of experts is recommending.

Read more...

Gizmodo

It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide. Usually, the buzz is positive, but there has been a persistent claim made about these drugs that would make any potential user wary: They don’t only help you lose weight—they supposedly…

Read more...

Gizmodo

Scientists in the U.K. seem to have unearthed yet another benefit of exercise: It could make our bodies better at using up certain kinds of fat. In a new study out this week, researchers found that endurance athletes were much better at burning off saturated fat compared to sedentary people with type 2 diabetes—a…

Read more...

Gizmodo

New research might help you make the most of your exercising: Scientists tracked the long-term health of people living with obesity and found that those who exercised in the evening were the least likely to experience cardiovascular problems or to die compared to non-exercisers and those who exercised at other times.

Read more...

Gizmodo

The newest obesity drug on the market, Eli Lilly’s tirzepatide, may also help keep people’s blood pressure in check, new research out Monday has shown. The study looked at clinical trial participants and found that people taking it experienced a drop in their systolic blood pressure on average compared to a placebo…

Read more...

Gizmodo

A popular class of weight loss drugs may offer more lasting success than assumed, new data from Epic Research suggests. The study of medical records found that a slight majority of people who took GLP-1 drugs like semaglutide either maintained or improved their weight loss in the year after they stopped using the…

Read more...

Gizmodo

Few prescription drugs have entered the public consciousness as abruptly as Ozempic and Wegovy have in recent years. Novo Nordisk’s brand-name medications have become as synonymous with weight loss as Viagra and Cialis are with erectile dysfunction. But while 2023 has made it clear that these and similar drugs really…

Read more...

Gizmodo

Your snack habit may be even more calorie-dense than you think, recent research suggests. A study estimated that snacking contributes to around 20% of an average American’s daily caloric intake, and these snacks often add little nutritional value. The scientists found, though, that people with type 2 diabetes seem to…

Read more...